FDA Approval of Zepbound for Obstructive Sleep Apnea

FDA approves first medication for obstructive sleep apnea, Zepbound, which helps promote more restful sleep through weight loss. The drug activates hormones to reduce appetite and food intake, improving OSA symptoms. Side effects include nausea, diarrhea, and thyroid C-cell tumor risk.